Letter: should immunosuppressive therapy be started with adalimumab in Crohn's disease?

被引：2
|
作者：
Tursi, A. [1 ]
机构：
[1] ASL BAT, Gastroenterol Serv, Andria, BT, Italy
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2013年 / 37卷 / 07期
关键词：
D O I：
10.1111/apt.12216
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：752 / 753
页数：2
相关论文
共 50 条
  • [21] Adherence to Adalimumab Therapy in Crohn's Disease: A French Multicenter Experience
    Billioud, Vincent
    Laharie, David
    Filippi, Jerome
    Roblin, Xavier
    Oussalah, Abderrahim
    Chevaux, Jean-Baptiste
    Hebuterne, Xavier
    Bigard, Marc-Andre
    Peyrin-Biroulet, Laurent
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (01) : 152 - 159
  • [22] The Use of Concomitant Immunomodulators With Adalimumab Therapy in Pediatric Crohn's Disease
    Benkov, Keith J.
    Russell, George H.
    Samson, Charles
    Steiner, Steven
    King, Eileen
    Pratt, Jesse
    Eichner, Samantha
    Colletti, Richard B.
    GASTROENTEROLOGY, 2016, 150 (04) : S588 - S588
  • [23] The use of concomitant immunomodulators with adalimumab therapy in paediatric Crohn's disease
    Benkov, K.
    Russell, G.
    Samson, C.
    Steiner, S.
    King, E. C.
    Pratt, J.
    Eichner, S.
    Colletti, R. B.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S272 - S273
  • [24] Adalimumab and Azathioprine Combination Therapy for Crohn's Disease: A Shining Diamond?
    Fiorino, Gionata
    Danese, Silvio
    JOURNAL OF CROHNS & COLITIS, 2016, 10 (11): : 1257 - 1258
  • [25] Combination Therapy with Dose Optimized Thiopurine and Adalimumab in Crohn's Disease
    Grover, Zubin
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (09) : 1566 - 1567
  • [26] Pneumocystosis in a patient with Crohn's disease treated with combination therapy with adalimumab
    Desales, Ana L.
    Mendez-Navarro, Jorge
    Mendez-Tovar, Luis J.
    Ortiz-Olvera, Nayeli X.
    Cullen, Garret
    Ocampo, Joaquin
    Lemus, Willian
    Tun, Amina E.
    Mayoral-Zavala, Arturo
    Dehesa-Violante, Margarita
    JOURNAL OF CROHNS & COLITIS, 2012, 6 (04): : 483 - 487
  • [27] Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn's Disease (EXPLORER)
    Colombel, Jean-Frederic
    Ungaro, Ryan C.
    Sands, Bruce E.
    Siegel, Corey A.
    Wolf, Douglas C.
    Valentine, John F. .
    Feaga, Brian G.
    Neustifter, Blue
    Kadali, Harisha
    Nazarey, Pradeep
    James, Alexandra
    Jairath, Vipul
    Khan, Rana M. Qasim
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (07) : 1487 - 1496
  • [28] Quiescent Crohn's Disease: A Paradoxical Event During Adalimumab Therapy
    Jessamy, Kegan
    Rawlins, Sekou
    Umar, Jalaluddin
    Grewal, Serena
    Aswath, Ganesh
    Sangani, Ruchika
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S1343 - S1344
  • [29] Ventricular tachyarrhythmia after adalimumab therapy in a patient with Crohn's disease
    Eder, P.
    Lykowska-Szuber, L.
    Krela-Kazmierczak, I.
    Stawczyk-Eder, K.
    Linke, K.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2013, 76 (01): : 74 - 75
  • [30] Adalimumab induction for Crohn's disease
    Cottone, M
    Mocciaro, F
    Scimeca, D
    GASTROENTEROLOGY, 2006, 130 (06) : 1929 - 1929
12345